9 participants
Tremelimumab + Durvalumab(MEDI4736)+ Belinostat in Urothelial Carcinoma
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-05-07
- Start Date:
- 2022-01-14
- Completion:
- 2026-08-31
Conditions
- Infiltrating Urothelial Carcinoma, Sarcomatoid Variant
- Locally Advanced Urothelial Carcinoma
- Metastatic Urothelial Carcinoma
- Unresectable Urothelial Carcinoma
Interventions
- DRUG
- BIOLOGICAL
No Results Yet